Research ArticleDrug Discovery and Translational Medicine
Preclinical Characterization of ABT-348, a Kinase Inhibitor Targeting the Aurora, Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor, and Src Kinase Families
Keith B. Glaser, Junling Li, Patrick A. Marcotte, Terrance J. Magoc, Jun Guo, David R. Reuter, Paul Tapang, Ru-Qi Wei, Lori J. Pease, Mai H. Bui, Zehan Chen, Robin R. Frey, Eric F. Johnson, Donald J. Osterling, Amanda M. Olson, Jennifer J. Bouska, Yanping Luo, Michael L. Curtin, Cherrie K. Donawho, Michael R. Michaelides, Chris Tse, Steven K. Davidsen and Daniel H. Albert
Journal of Pharmacology and Experimental Therapeutics December 2012, 343 (3) 617-627; DOI: https://doi.org/10.1124/jpet.112.197087
Keith B. Glaser
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Junling Li
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Patrick A. Marcotte
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Terrance J. Magoc
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Jun Guo
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
David R. Reuter
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Paul Tapang
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Ru-Qi Wei
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Lori J. Pease
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Mai H. Bui
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Zehan Chen
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Robin R. Frey
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Eric F. Johnson
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Donald J. Osterling
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Amanda M. Olson
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Jennifer J. Bouska
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Yanping Luo
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Michael L. Curtin
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Cherrie K. Donawho
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Michael R. Michaelides
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Chris Tse
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Steven K. Davidsen
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Daniel H. Albert
Abbott Oncology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleDrug Discovery and Translational Medicine
Preclinical Characterization of the Kinase Inhibitor ABT-348
Keith B. Glaser, Junling Li, Patrick A. Marcotte, Terrance J. Magoc, Jun Guo, David R. Reuter, Paul Tapang, Ru-Qi Wei, Lori J. Pease, Mai H. Bui, Zehan Chen, Robin R. Frey, Eric F. Johnson, Donald J. Osterling, Amanda M. Olson, Jennifer J. Bouska, Yanping Luo, Michael L. Curtin, Cherrie K. Donawho, Michael R. Michaelides, Chris Tse, Steven K. Davidsen and Daniel H. Albert
Journal of Pharmacology and Experimental Therapeutics December 1, 2012, 343 (3) 617-627; DOI: https://doi.org/10.1124/jpet.112.197087
Research ArticleDrug Discovery and Translational Medicine
Preclinical Characterization of the Kinase Inhibitor ABT-348
Keith B. Glaser, Junling Li, Patrick A. Marcotte, Terrance J. Magoc, Jun Guo, David R. Reuter, Paul Tapang, Ru-Qi Wei, Lori J. Pease, Mai H. Bui, Zehan Chen, Robin R. Frey, Eric F. Johnson, Donald J. Osterling, Amanda M. Olson, Jennifer J. Bouska, Yanping Luo, Michael L. Curtin, Cherrie K. Donawho, Michael R. Michaelides, Chris Tse, Steven K. Davidsen and Daniel H. Albert
Journal of Pharmacology and Experimental Therapeutics December 1, 2012, 343 (3) 617-627; DOI: https://doi.org/10.1124/jpet.112.197087
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement